Would you have Vertigo when you have Hyperparathyroidism?

Summary

Vertigo is found among people with Hyperparathyroidism, especially for people who are female, 60+ old, take medication Zemplar and have Hypertension. We study 65 people who have Vertigo and Hyperparathyroidism from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Hyperparathyroidism

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium) can be treated by Vitamin d, Levothyroxine sodium, Calcium, Methimazole, Hectorol (latest reports from 2,471 Hyperparathyroidism patients)

Vertigo

Vertigo has been reported by people with breathing difficulty, pain, weakness, diarrhea, fatigue (latest reports from 198,821 Vertigo patients).

On Aug, 31, 2016

65 people who have Hyperparathyroidism and Vertigo are studied.


Number of reports submitted per year:

Would you have Vertigo when you have Hyperparathyroidism?

Gender of people who have Hyperparathyroidism and experience Vertigo *:

  • female: 55.74 %
  • male: 44.26 %

Age of people who have Hyperparathyroidism and experience Vertigo *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.3 %
  • 60+: 90.7 %

Severity if Hyperparathyroidism and experience Vertigo *:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Hypertension (11 people, 16.92%)
  • Prophylaxis (3 people, 4.62%)
  • Diabetes Mellitus (3 people, 4.62%)
  • Anaemia (3 people, 4.62%)
  • Type 2 Diabetes Mellitus (2 people, 3.08%)
  • Osteoporosis (2 people, 3.08%)
  • Hypothyroidism (2 people, 3.08%)
  • Hyperuricaemia (2 people, 3.08%)
  • Dyslipidaemia (2 people, 3.08%)
  • Constipation (2 people, 3.08%)

Most common drugs for these people *:

  • Zemplar (54 people, 83.08%)
  • Levothyroxine Sodium (7 people, 10.77%)
  • Allopurinol (7 people, 10.77%)
  • Simvastatin (5 people, 7.69%)
  • Plavix (5 people, 7.69%)
  • Nexium (5 people, 7.69%)
  • Amlodipine (5 people, 7.69%)
  • Renagel (4 people, 6.15%)
  • Hectorol (4 people, 6.15%)
  • Cinacalcet Hydrochloride (4 people, 6.15%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Vertigo and Hyperparathyroidism?

Browse all symptoms of Hyperparathyroidism

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Vertigo

Vertigo

Other conditions that could case Vertigo

Vertigo

Can you answer these questions?

More questions for: Hyperparathyroidism, Vertigo

You may be interested in these reviews

More reviews for: Hyperparathyroidism, Vertigo


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.